The Food and Drugs Authority (FDA) has issued a public health alert after uncovering falsified HIV test kits being sold in Ghana, warning of the dangers of inaccurate results and delayed treatment. In its statement, the FDA identified the counterfeit products as VISITECT CD4 Advanced Disease test kits bearing lot number 0001586.
These kits, the Authority explained, are fake and fail to meet approved standards. The FDA noted that the falsified kits incorrectly list Omega Diagnostics Limited as the manufacturer. In reality, the authentic VISITECT CD4 test kits are produced by AccuBio Limited, carry lot number 0002172, and include proper product details. The Authority further highlighted inconsistencies in the printed dates: while the genuine kits were manufactured in July 2025 and expire in November 2026, the counterfeit versions claim an August 2024 manufacturing date and a January 2027 expiry date.
The FDA noted that such differences in manufacturer information and dates should serve as warning signs. It advised healthcare providers to pay close attention to these details when handling medical products. The Authority said that the presence of falsified HIV test kits poses a serious threat to public health. It noted that accurate testing is essential in HIV care, and that any error can have major consequences.
The FDA has cautioned that falsified HIV test kits could lead to dangerous consequences—delaying treatment for those living with HIV or causing needless anxiety for individuals who receive false-positive results. “Your health is too important to risk,” the Authority emphasised, urging heightened vigilance across the health sector.
As an immediate measure, hospitals, laboratories, and testing centres have been directed to inspect their stock of VISITECT CD4 test kits. Any kits bearing lot number 0001586 must be withdrawn from use without delay and returned to the nearest FDA office for safe disposal.
The Authority further encouraged health professionals and the public to report suspected counterfeit medical products through its official channels. It confirmed that investigations are underway to trace the source of the falsified kits and hold those responsible accountable. The FDA also reminded the public to verify medical products before use to safeguard against potential harm.
Source: Myjoyonline.com
